|
1
|
Saida T: Melanoma and Non-melanoma skin
cancers. Gan To Kagaku Ryoho. 45:612–613. 2018.(In Japanese).
PubMed/NCBI
|
|
2
|
Gallego Y, Mendicute J, Ruiz M, Ruiz I and
Ubeda M: Melanocytoma of the ciliary body. Arch Soc Esp Oftalmol.
80:109–112. 2005.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lang J and MacKie RM: Prevalence of exon
15 BRAF mutations in primary melanoma of the superficial
spreading, nodular, acral, and lentigo maligna subtypes. J Invest
Dermatol. 125:575–579. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakamura Y II: Diagnosis and treatment for
nail Apparatus (Subungual) Melanoma]. Gan to Kagaku Ryoho.
45:619–621. 2018.(In Japanese). PubMed/NCBI
|
|
5
|
Chen F, Zhang X, Ma K, Madajewski B,
Benezra M, Zhang L, Phillips E, Turker MZ, Gallazzi F,
Penate-Medina O, et al: Melanocortin-1 receptor-targeting
ultrasmall silica nanoparticles for dual-modality human melanoma
imaging. ACS Appl Mater Interfaces. 10:4379–4393. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo W, Wang H, Yang Y, Guo S, Zhang W, Liu
Y, Yi X, Ma J, Zhao T, Liu L, et al: Down-regulated miR-23a
contributes to the metastasis of cutaneous melanoma by promoting
autophagy. Theranostics. 7:2231–2249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye Z, Dong H, Li Y, Ma T, Huang H, Leong
HS, Eckel-Passow J, Kocher JA, Liang H and Wang L: Prevalent
homozygous deletions of type I interferon and defensin genes in
human cancers associate with immunotherapy resistance. Clin Cancer
Res. 24:3299–3308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Chen P, Chen SS, Ma T, Shi G, Zhou
Y, Li J and Sheng L: miR-106b-5p promotes cell cycle
progression of malignant melanoma by targeting PTEN. Oncol
Rep. 39:331–337. 2018.PubMed/NCBI
|
|
9
|
Jiang L, Tu Y, Hu X, Bao A, Chen H, Ma X,
Doyle T, Shi H and Cheng Z: Pilot study of 64Cu(I) for
PET imaging of melanoma. Sci Rep. 7:25742017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu J, Wu X, Yan J, Yu H, Xu L, Chi Z,
Sheng X, Si L, Cui C, Dai J, et al: Anti-GD2/4-1BB chimeric antigen
receptor T cell therapy for the treatment of Chinese melanoma
patients. J Hematol Oncol. 11:12018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sonoda Y, Kijima M and Uchida H: Melanoma
of the choroid. Nihon Ganka Kiyo. 19:828–831. 1968.(In Japanese).
PubMed/NCBI
|
|
12
|
Liu SM, Lin CH, Lu J, Lin IY, Tsai MS,
Chen MH and Ma N: miR-596 modulates melanoma growth by regulating
cell survival and death. J Invest Dermatol. 138:911–921. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma Y, Cheng X, Wang F, Pan J, Liu J, Chen
H, Wang Y and Cai L: ING4 inhibits proliferation and induces
apoptosis in human melanoma A375 cells via the Fas/Caspase-8
apoptosis pathway. Dermatology. 232:265–272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin S, Lv J, Peng P, Cai C, Deng J, Deng
H, Li X and Tang X: Bufadienolides induce p53-mediated apoptosis in
esophageal squamous cell carcinoma cells in vitro and in
vivo. Oncol Lett. 15:1566–1572. 2018.PubMed/NCBI
|
|
15
|
Raymond-Hamet, . Toxicity of orally
administered bufotalin. C R Seances Soc Biol Fil. 152:571–574.
1958.(In French). PubMed/NCBI
|
|
16
|
Pettit GR and Kamano Y: Bufadienolides.
21. Synthesis of cinobufagin from bufotalin. J Org Chem.
37:4040–4044. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang DM, Liu JS, Tang MK, Yiu A, Cao HH,
Jiang L, Chan JY, Tian HY, Fung KP and Ye WC: Bufotalin from
Venenum bufonis inhibits growth of multidrug resistant HepG2 cells
through G2/M cell cycle arrest and apoptosis. Eur J
Pharmacol. 692:19–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wen L, Liu L, Wen L, Yu T and Wei F:
Artesunate promotes G2/M cell cycle arrest in MCF7 breast cancer
cells through ATM activation. Breast Cancer. 25:681–686. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yin PH, Liu X, Qiu YY, Cai JF, Qin JM, Zhu
HR and Li Q: Antitumor activity and apoptosis-regulation mechanisms
of bufalin in various cancers: New hope for cancer patients. Asian
Pac J Cancer Prev. 13:5339–5343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren Y, Zhang SW, Xie ZH, Xu XM, Chen LL,
Lou ZG, Weng GB and Yao XP: Cantharidin induces G2/M
arrest and triggers apoptosis in renal cell carcinoma. Mol Med Rep.
14:5614–5618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang CC, Hung CF and Chen BH: Preparation
of coffee oil-algae oil-based nanoemulsions and the study of their
inhibition effect on UVA-induced skin damage in mice and melanoma
cell growth. Int J Nanomedicine. 12:6559–6580. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang C, Liang C, Feng W, Xia X, Chen F,
Qiao E, Zhang X, Chen D, Ling Z and Yang H: ICT1 knockdown
inhibits breast cancer cell growth via induction of cell cycle
arrest and apoptosis. Int J Mol Med. 39:1037–1045. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang WW, Tsai SC, Peng SF, Lin MW, Chiang
JH, Chiu YJ, Fushiya S, Tseng MT and Yang JS: Kaempferol induces
autophagy through AMPK and AKT signaling molecules and causes
G2/M arrest via downregulation of CDK1/cyclin B in
SK-HEP-1 human hepatic cancer cells. Int J Oncol. 42:2069–2077.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li P, Ding N, Zhang W and Chen L: COPS2
antagonizes OCT4 to accelerate the G2/M transition of mouse
embryonic stem cells. Stem Cell Reports. 11:317–324. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Anger M, Stein P and Schultz RM: CDC6
requirement for spindle formation during maturation of mouse
oocytes. Biol Reprod. 72:188–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li S and Guo L: Pseudolaric acid B induces
G2/M arrest and inhibits invasion and migration in HepG2 hepatoma
cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 34:59–64. 2018.(In
Chinese). PubMed/NCBI
|
|
28
|
She H and Mao Z: Study of ATM
phosphorylation by Cdk5 in neuronal cells. Methods Mol Biol.
1599:363–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Blackford AN and Jackson SP: ATM, ATR, and
DNA-PK: The trinity at the heart of the DNA damage response. Mol
Cell. 66:801–817. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ashley AK and Kemp CJ: DNA-PK, ATM, and
ATR: PIKKing on p53. Cell Cycle. 17:275–276. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hennessy BT, Smith DL, Ram PT, Lu Y and
Mills GB: Exploiting the PI3K/AKT pathway for cancer drug
discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu QG, Yu J, Guo XG, Hou GJ, Yuan SX, Yang
Y, Yang Y, Liu H, Pan ZY, Yang F, et al: IL-17A promotes the
invasion-metastasis cascade via the AKT pathway in hepatocellular
carcinoma. Mol Oncol. 12:936–952. 2018. View Article : Google Scholar : PubMed/NCBI
|
